These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 15055219)

  • 1. Somatropin in Prader-Willi syndrome.
    Prescrire Int; 2004 Feb; 13(69):21. PubMed ID: 15055219
    [No Abstract]   [Full Text] [Related]  

  • 2. Sudden death in growth hormone-treated children with Prader-Willi syndrome.
    Van Vliet G; Deal CL; Crock PA; Robitaille Y; Oligny LL
    J Pediatr; 2004 Jan; 144(1):129-31. PubMed ID: 14722532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sudden death in Prader-Willi syndrome: brief review of five additional cases. Concerning the article by U. Eiholzer et al.: Deaths in children with Prader-Willi syndrome. A contribution to the debate about the safety of growth hormone treatment in children with PWS (Horm Res 2005;63:33-39).
    Bakker B; Maneatis T; Lippe B
    Horm Res; 2007; 67(4):203-4. PubMed ID: 17164585
    [No Abstract]   [Full Text] [Related]  

  • 4. Growth hormone and respiratory compromise in Prader-Willi Syndrome.
    Wilson SS; Cotterill AM; Harris MA
    Arch Dis Child; 2006 Apr; 91(4):349-50. PubMed ID: 16551791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KIGS highlights: growth hormone treatment in Prader-Willi Syndrome.
    Tauber M; Cutfield W
    Horm Res; 2007; 68 Suppl 5():48-50. PubMed ID: 18174707
    [No Abstract]   [Full Text] [Related]  

  • 6. Growth hormone therapy in children with Prader-Willi syndrome.
    Franzese A; Romano A; Spagnuolo MI; Ruju F; Valerio G
    J Pediatr; 2006 Jun; 148(6):846; author reply 846-7. PubMed ID: 16769405
    [No Abstract]   [Full Text] [Related]  

  • 7. KIGS: 20 years.
    Ranke M
    Horm Res; 2007; 68 Suppl 5():40. PubMed ID: 18174705
    [No Abstract]   [Full Text] [Related]  

  • 8. Prader-Willi syndrome: medical prevention and behavioral challenges.
    Benarroch F; Hirsch HJ; Genstil L; Landau YE; Gross-Tsur V
    Child Adolesc Psychiatr Clin N Am; 2007 Jul; 16(3):695-708. PubMed ID: 17562587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Body mass index in children with Prader-Willi Syndrome during human growth hormone therapy: a real world situation.
    Dewan T; Chanoine JP
    J Pediatr; 2009 May; 154(5):777-8; author reply 779. PubMed ID: 19364570
    [No Abstract]   [Full Text] [Related]  

  • 10. GH treatment reduces total ghrelin in Prader-Willi syndrome (PWS) and may confound ghrelin studies in young PWS children.
    Hauffa BP; Petersenn S
    Clin Endocrinol (Oxf); 2009 Jul; 71(1):155-6. PubMed ID: 19178506
    [No Abstract]   [Full Text] [Related]  

  • 11. Growth hormone treatment and adverse events in Prader-Willi syndrome: data from KIGS (the Pfizer International Growth Database).
    Craig ME; Cowell CT; Larsson P; Zipf WB; Reiter EO; Albertsson Wikland K; Ranke MB; Price DA;
    Clin Endocrinol (Oxf); 2006 Aug; 65(2):178-85. PubMed ID: 16886957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. POI: a score to modulate GH treatment in children with Prader-Willi syndrome.
    Salvatoni A; Berini J; Chiumello G; Crinò A; Di Candia S; Gargantini L; Grugni G; Iughetti L; Luce A; Musolino G; Sogno Valin P; Spica Russotto V; Trifirò G
    Horm Res Paediatr; 2012; 78(3):201-2. PubMed ID: 22986481
    [No Abstract]   [Full Text] [Related]  

  • 13. Prader-Willi syndrome: who can have growth hormone?
    Stafler P; Wallis C
    Arch Dis Child; 2008 Apr; 93(4):341-5. PubMed ID: 18089632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute lymphoblastic leukemia in a patient with Prader-Willi syndrome under growth hormone therapy.
    Kato M; Mugishima H; Chin M; Urakami T; Harada K
    Pediatr Int; 2005 Jun; 47(3):336-7. PubMed ID: 15910463
    [No Abstract]   [Full Text] [Related]  

  • 15. Growth hormone therapy in Prader-Willi syndrome.
    Davies PS
    Int J Obes Relat Metab Disord; 2001 Jan; 25(1):2-7. PubMed ID: 11244451
    [No Abstract]   [Full Text] [Related]  

  • 16. Growth hormone therapy for Prader-Willi syndrome: a critical appraisal.
    Allen DB; Carrel AL
    J Pediatr Endocrinol Metab; 2004 Sep; 17 Suppl 4():1297-306. PubMed ID: 15506076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac tamponade due to systemic lupus erythematosus in patient with Prader-Willi syndrome after growth hormone therapy.
    Kuramochi Y; Kato T; Sudou M; Sugano H; Takagi H; Morita T
    Lupus; 2007; 16(6):447-9. PubMed ID: 17664237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is scoliosis an issue for giving growth hormone to children with Prader-Willi syndrome?
    Diene G; de Gauzy JS; Tauber M
    Arch Dis Child; 2008 Dec; 93(12):1004-6. PubMed ID: 19028967
    [No Abstract]   [Full Text] [Related]  

  • 19. Growth hormone therapy in adults and children.
    Levy RM
    N Engl J Med; 2000 Feb; 342(5):359. PubMed ID: 10660404
    [No Abstract]   [Full Text] [Related]  

  • 20. Growth hormone treatment completely normalizes adult height and improves body composition in Prader-Willi syndrome: experience from KIGS (Pfizer International Growth Database).
    Lindgren AC; Lindberg A
    Horm Res; 2008; 70(3):182-7. PubMed ID: 18663319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.